Renal Function between Tenofovir and Entecavir in Post-Liver Transplant Hepatitis B Patients

Sang Jin KIM ,  Jong Man KIM

대한외과학회 학술대회 초록집

2018 .11

국내 만성 B형 간염 환자의 경구용 항바이러스제 사용 현황 분석

제남경

한국임상약학회지

2016 .01

Dyslipidemia in chronic hepatitis B patients on tenofovir alafenamide: Facts and puzzles

Hung-Yao Lin ,  Tai-Chung Tseng

Clinical and Molecular Hepatology

2022 .04

Cardiovascular risk of tenofovir disoproxil fumarate or tenofovir alafenamide in patients with chronic hepatitis B: More questions than an answer

Pin-Nan Cheng ,  Ming-Lung Yu

Clinical and Molecular Hepatology

2024 .04

Entecavir와 한의약 치료를 병행한 후 HBV-DNA가 음전된 만성 B형 간염 환자 증례 보고

한창우

대한한방내과학회지

2017 .01

Is the Prevalence of Chronic Hepatitis B Really Increasing in Korea?

Jang Byoung Kuk

Journal of Korean Medical Science

2024 .01

The efficacy of Tenofovir-based therapy in patients showing suboptimal response to Entecavir-Adefovr combination therapy

김정한 ,  안성현 ,  고순영 외 3명

Clinical and Molecular Hepatology

2016 .01

Entecavir plus tenofovir versus entecavir plus adefovir in chronic hepatitis B patients with a suboptimal response to lamivudine and adefovir combination therapy

박정길 ,  박수영

Clinical and Molecular Hepatology

2015 .01

Recovery of Tenofovir-induced Nephrotoxicity following Switch from Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in Human Immunodeficiency Virus-Positive Patients

Seo Jun-Won ,  Kim Kichun ,  Jun Kang Il 외 13명

Infection and Chemotherapy

2020 .01

Current and future strategies for the treatment of chronic hepatitis C

Oma ,  Alshuwaykh ,  Paul Y. Kwo

Clinical and Molecular Hepatology

2021 .01

Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B

Chung-Il Wi ,  W. Ray Kim ,  John B. G 외 5명

Gut and Liver

2016 .01

2017 KASL clinical practice guidelines management of hepatitis C: Treatment of chronic hepatitis C

The Ko ,  ean Association fo ,  the Study of the Live

Clinical and Molecular Hepatology

2018 .01

Chronic Hepatitis C Virus Infection, Why Not Treat Now?

박경수

대한류마티스학회지

2018 .01

Real-World Incidence of Suboptimal Response to Anti-Tumor Necrosis Factor Therapy for Ulcerative Colitis: A Nationwide Population-Based Study

Shin Ju-Young ,  Pa ,  k Hye-Min 외 4명

Gut and Liver

2021 .11

Efficacy of entecavir verses lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with allogeneic stem cell transplant

Dexton JOHNS

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .12

A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B

Yang Hyun Baek

Clinical and Molecular Hepatology

2020 .01

Quantitative Hepatitis B Surface Antigen, the Trustworthy Biomarker for Functional Cure of Chronic Hepatitis B

Choi Jonggi

Gut and Liver

2023 .03

How does hepatic steatosis affect the outcome of patients with chronic hepatitis B?

Jung Hwan Yu ,  Jin-Woo Lee

Clinical and Molecular Hepatology

2019 .01

Should physicians go out of the way to differentiate between acute hepatitis B and acute exacerbation of chronic hepatitis B?

Hyun Woong Lee

Clinical and Molecular Hepatology

2020 .01

Entecavir+tenofovir vs. lamivudine/telbivudine+adefovir in chronic hepatitis B patients with prior suboptimal response

Hyun Young Woo ,  Jun Yong Pa ,  k 외 8명

Clinical and Molecular Hepatology

2020 .01